f 4 has been researched along with s 8932 in 1 studies
| Studies (f 4) | Trials (f 4) | Recent Studies (post-2010) (f 4) | Studies (s 8932) | Trials (s 8932) | Recent Studies (post-2010) (s 8932) |
|---|---|---|---|---|---|
| 5 | 0 | 3 | 1,246 | 52 | 1,207 |
| Protein | Taxonomy | f 4 (IC50) | s 8932 (IC50) |
|---|---|---|---|
| NS5 | Zika virus | 1.36 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 3.525 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beadle, JR; Carlin, AF; Clark, AE; Freshman, JE; Garretson, AF; Hostetler, KY; Lo, MK; McMillan, RE; Montgomery, JM; Murphy, J; Schooley, RT; Spiropoulou, CF; Valiaeva, N; Zhang, XQ | 1 |
1 other study(ies) available for f 4 and s 8932
| Article | Year |
|---|---|
Enhanced broad spectrum in vitro antiviral efficacy of 3-F-4-MeO-Bn, 3-CN, and 4-CN derivatives of lipid remdesivir nucleoside monophosphate prodrugs.
Topics: Antiviral Agents; Glycerol; Lipids; Nucleosides; Prodrugs | 2023 |